Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.
Clinical trial NCT06600022 · RECRUITING
Trial details
- NCT number
- NCT06600022
- Sponsor
- Sinocelltech Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2027-04-30
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.